期刊文献+

肠道菌群与非酒精性脂肪性肝病关系的研究进展 被引量:5

Relationship between gut microbiota and non-alcoholic fatty liver disease
暂未订购
导出
摘要 非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)是西方国家及一些亚洲国家中常见的慢性肝脏疾病,目前在世界范围内的发病率逐渐上升。NAFLD包括单纯性脂肪肝、非酒精性脂肪性肝炎(non-alcoholic steatohepatitis,NASH)、NASH相关性肝硬化及肝癌等一系列疾病。NASH进展为肝硬化、肝癌的风险大,预后差,是世界范围内沉重的医疗负担。NAFLD是由多种因素引起的疾病,除了环境因素及遗传因素外,近年来不断有证据提示,肠道菌群在NAFLD的发生、发展过程中起一定作用,本文就肠道菌群与NAFLD关系的研究进展作一概述。 Non-alcoholic fatty liver disease( NAFLD) is a common chronic liver disease in Western countries and some Asian countries,and currently the incidence of NAFLD continues to increase worldwide. NAFLD encompasses a pathologic spectrum of disease,from relatively benign accumulation of lipid( steatosis) to progressive non-alcoholic steatohepatitis( NASH) associated with inflammation,fibrosis,necrosis and hepatocellular carcinoma. Without an effective available treatment,the prognosis of NASH is poor due to the high risk of progressive liver diseases such as cirrhosis and carcinoma,making it a great burden in health worldwide. NAFLD is a multifactorial disease,apart from environmental and genetical factors,recent studies suggest that gut microbiota might be implicated in the pathogenesis of NAFLD.Here,the relationship between gut microbiota and NAFLD was reviewed.
出处 《胃肠病学和肝病学杂志》 CAS 2017年第10期1103-1106,共4页 Chinese Journal of Gastroenterology and Hepatology
关键词 肠道菌群 非酒精性脂肪性肝病 胰岛素抵抗 Gut microbiota Non-alcoholic fatty liver disease Insulin resistance
  • 相关文献

参考文献3

二级参考文献20

  • 1Raffi Karagozian,Zoltán Derdák,Gy?rgy Baffy.Obesity-associated mechanisms of hepatocarcinogenesis[J]. Metabolism . 2014
  • 2Bernd Schnabl,David A. Brenner.Interactions Between the Intestinal Microbiome and Liver Diseases[J]. Gastroenterology . 2014
  • 3Samuel Buck S,Shaito Abdullah,Motoike Toshiyuki,Rey Federico E,Backhed Fredrik,Manchester Jill K,Hammer Robert E,Williams S Clay,Crowley Jan,Yanagisawa Masashi,Gordon Jeffrey I.Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41[].Proceedings of the National Academy of Sciences of the United States of America.2008
  • 4L. K. Brahe,A. Astrup,L. H. Larsen.Is butyrate the link between diet, intestinal microbiota and obesity‐related metabolic diseases?[J]. Obes Rev . 2013 (12)
  • 5Diego Rincón,Javier Vaquero,Ana Hernando,Evelyn Galindo,Cristina Ripoll,Marta Puerto,Magdalena Salcedo,Rubén Francés,Ana Matilla,María V. Catalina,Gerardo Clemente,José Such,Rafael Ba?ares.Oral probiotic VSL #3 attenuates the circulatory disturbances of patients with cirrhosis and ascites[J]. Liver Int . 2014 (10)
  • 6Manish Kumar Lunia,Barjesh Chander Sharma,Praveen Sharma,Sanjeev Sachdeva,Siddharth Srivastava.Probiotics Prevent Hepatic Encephalopathy in Patients With Cirrhosis: A Randomized Controlled Trial[J]. Clinical Gastroenterology and Hepatology . 2014
  • 7Reiner Wiest,Melissa Lawson,Markus Geuking.Pathological bacterial translocation in liver cirrhosis[J]. Journal of Hepatology . 2014 (1)
  • 8Gyongyi Szabo.Gut–Liver Axis in Alcoholic Liver Disease[J]. Gastroenterology . 2014
  • 9S.M. O’Mahony,G. Clarke,Y.E. Borre,T.G. Dinan,J.F. Cryan.Serotonin, tryptophan metabolism and the brain-gut-microbiome axis[J]. Behavioural Brain Research . 2014
  • 10Graham J. Dockray.Gastrointestinal hormones and the dialogue between gut and brain[J]. J Physiol . 2014 (14)

共引文献85

同被引文献63

引证文献5

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部